Thromboprophylaxis for Patients Undergoing Surgical Resection for Colon Cancer
Status:
Completed
Trial end date:
2010-09-01
Target enrollment:
Participant gender:
Summary
The blood thinner "tinzaparin" might increase survival in patients with colon cancer
undergoing surgical resection. The investigators want to assess if a trial allocating
patients to prolonged treatment with tinzaparin versus standard of care is feasible.